Schwann cells as a therapeutic target for peripheral neuropathies
- PMID: 20874704
- PMCID: PMC4053445
- DOI: 10.2174/187152710793237412
Schwann cells as a therapeutic target for peripheral neuropathies
Abstract
Schwann cells, the myelin forming cells in the peripheral nervous system, play a key role in the pathology of various inflammatory, metabolic and hereditary polyneuropathies. Advances in identifying growth factors and signaling molecules that are expressed by Schwann cells have paved the way for development of new treatment strategies that are aimed to improve the protective and regenerative properties of Schwann cells in peripheral nerve disorders. These include the exogenous application of growth factors and neurohormones which have been advanced into clinical trials in humans, and transplantation paradigms that have been moved into late stage preclinical models. In this review we will discuss the latest developments in these therapeutic approaches with special regard to peripheral nerve disorders, in which progress in basic research has already been translated into clinical trials, including HIV-associated distal sensory polyneuropathy and diabetic neuropathy.
References
-
- Chen Z, Yu W, Strickland S. Peripheral regeneration. Annu Rev Neurosci. 2007;30:209–233. - PubMed
-
- Hoke A. Mechanisms of Disease: what factors limit the success of peripheral nerve regeneration in humans? Nat Clin Pract Neurol. 2006;2(8):448–454. - PubMed
-
- Sherman D, Brophy P. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci. 2005;6(9):683–690. - PubMed
-
- Sulaiman O, Gordon T. Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size. Glia. 2000;32(3):234–246. - PubMed
-
- Fu S, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol. 14(1-2):67–116. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical